CASP9 and urinary bladder carcinoma: In this study, JS-K promoted ROS levels, increased cytotoxicity and caspase-3/7 activity, and activated caspase-9 protein in bladder cancer cells in a concentration-dependent manner; these effects, in turn, induced cellular apoptosis.